{"data":{"id":"us/21-cfr-520.2598","jurisdiction":"us","citation":"21 CFR 520.2598","heading":"Trilostane.","body":"(a) Specifications. Each capsule contains 5, 10, 20, 30, 60, or 120 milligrams (mg) trilostane.\n(b) Sponsor. See No. 043264 in § 510.600 of this chapter.\n(c) Conditions of use in dogs—(1) Amount. The starting dose is 1.0 to 3.0 milligrams per pound (2.2 to 6.7 milligrams per kilogram) once a day.\n(2) Indications for use. For the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs.\n(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"e33a90f0c046b4bc68931fe0354f4d8c38e706c775c664eda1bb90f20c126475","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-520.2582","next":"us/21-cfr-520.2604"},"notice":"GroundRules: Original legal text. Not legal advice."}